Whitehawk Therapeutics
Price & Volume
Stats
See more52W Range | $1.39-$3.76 |
Market Cap | $126.3M |
Shares Short | 735,610 |
Financials
See moreRevenue (12 Mos) | $14.3M |
Revenue Growth (YoY) | 33.5% |
Gross Profit (12 Mos) | -$73.4M |
Diluted EPS | -$0.64 |
News
See moreYahoo Finance • 3 months ago
Whitehawk Therapeutics GAAP EPS of -$0.26 misses by $0.33
Yahoo Finance • 3 months ago
Tempus partners with Whitehawk Therapeutics to advance cancer research
Yahoo Finance • 6 months ago
US Personalized Medicine Market Trends and Company Analysis Report 2025-2033 Featuring Abbott, GE, Aadi Bioscience, Illumina, QIAGEN, Eli Lilly and Co, Takeda, AbbVie, F. Hoffmann-La Roche
Yahoo Finance • 7 months ago
Whitehawk Therapeutics to Participate in H.C. Wainwright "HCW@Home" Series
About
CEO | Dr. David J. Lennon Ph.D. |
CFO | Mr. Scott M. Giacobello CPA |
Address | 2 Headquarters Plaza, Morristown, NJ, United States, 07960 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 22 |
